ArticleFrontiers in immunology2026

Targeting SYK enhances responses to radiotherapy and PD-1 blockade with myeloid immune remodeling in breast cancer.

Yiqun Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.